Lyall A, Mc Adam T K, Townend J, Loudon M A
Department of Surgery, Aberdeen Royal Infirmary, Aberdeen, UK.
Colorectal Dis. 2007 Nov;9(9):801-7. doi: 10.1111/j.1463-1318.2006.01197.x.
Anastomotic complications following sphincter saving rectal surgery remains a significant clinical problem in rectal cancer surgery. Preoperative combined modality therapy followed by anterior resection with total mesorectal excision (TME) has become the preferred treatment paradigm for locally advanced rectal cancer. However, its impact on anastomotic complications has not been adequately evaluated. This study aimed to assess the relationship between the response of the primary tumour to neo-adjuvant therapy with anastomotic complications and to evaluate the effect of other clinico-pathological factors previously implicated, in this patient cohort.
A total of 119 consecutive patients with primary rectal cancer were assessed of which there were 87 anterior resections. A prospectively collected database was queried to determine the incidence of anastomotic complications, association with response to neo-adjuvant therapy and other clinico-pathological factors. Data were analysed with SPSS 14.0.
Anterior resection was performed in 87/111 (78.4%) patients of which 46/84 (56%) were low resections, with an abdominoperineal excision of rectum rate of 11/111 (9.9%). Anastomotic complications were seen as clinical leaks in 10/87 (11.5%) and late colo-visceral fistulae in 2/87 (2.2%) patients. Subclinical/ radiological 'leaks' were quantified as 4/87 (4.5%). A good pathological response to neo-adjuvant therapy was found to be strongly associated with anastomotic complications (P = 0.006). Presence of a perioperative cardiac event was the only other clinical factor associated with anastomotic complications (P = 0.004) in our study.
Rectal cancer treated with neo-adjuvant therapy and radical resection with TME for better local control may be associated with greater anastomotic complications particularly when a good pathological response is seen.
保留括约肌的直肠癌手术后吻合口并发症仍是直肠癌手术中一个重要的临床问题。术前综合治疗后行全直肠系膜切除术(TME)的前切除术已成为局部晚期直肠癌的首选治疗模式。然而,其对吻合口并发症的影响尚未得到充分评估。本研究旨在评估原发性肿瘤对新辅助治疗的反应与吻合口并发症之间的关系,并评估该患者队列中先前涉及的其他临床病理因素的影响。
对119例连续性原发性直肠癌患者进行评估,其中87例行前切除术。查询前瞻性收集的数据库,以确定吻合口并发症的发生率、与新辅助治疗反应的相关性以及其他临床病理因素。数据用SPSS 14.0进行分析。
87/111(78.4%)例患者行前切除术,其中46/84(56%)例为低位切除术,腹会阴联合直肠癌切除率为11/111(9.9%)。10/87(11.5%)例患者出现吻合口并发症,表现为临床漏,2/87(2.2%)例患者出现晚期结肠内脏瘘。亚临床/影像学“漏”量化为4/87(4.5%)。发现对新辅助治疗的良好病理反应与吻合口并发症密切相关(P = 0.006)。围手术期心脏事件是本研究中与吻合口并发症相关的唯一其他临床因素(P = 0.004)。
经新辅助治疗和TME根治性切除以实现更好的局部控制的直肠癌可能与更高的吻合口并发症相关,尤其是当出现良好的病理反应时。